title: Direct effects of chemoradiotherapy following esophagectomy.
abstract: BACKGROUND
  Esophageal cancer is a major cause of morbidity and mortality, but despite continuing research, few effective therapies have been identified. In recent years, surgical resection following chemoradiotherapy has been associated with improved survival in several clinical models.
  
  
  OBJECTIVE
  In a prospective, observational study, we evaluated the direct effects of chemoradiotherapy on postoperative mortality, morbidity, and inflammatory response in patients following esophagectomy.
  
  
  METHODS
  The study cohort was divided into two groups: the first group received preoperative chemoradiotherapy, while the second group had surgical intervention without prior treatment. Nutritional status was evaluated for the members of both patient groups at various time points.
  
  
  RESULTS
  Preoperative chemoradiotherapy did not influence morbidity or organ function, and the postoperative inflammatory response did not show immunosuppressive side effects directly after surgery.
  
  
  CONCLUSIONS
  Preoperative chemoradiotherapy does not improve postoperative organ function, inflammatory response or nutritional status in the patients. These findings may help to improve outcome in patients with esophageal cancer in the future.
authors.affiliation: Department of Anesthesiology and Intensive Therapy, University of Pecs, Pecs, Hungary.
authors.forename: S
authors.initials: S
authors.lastname: Marton
authors.forename: V
authors.initials: V
authors.lastname: Juhasz
authors.forename: L
authors.initials: L
authors.lastname: Bogar
authors.forename: A
authors.initials: A
authors.lastname: Papp
authors.forename: L
authors.initials: L
authors.lastname: Cseke
authors.forename: P O
authors.initials: PO
authors.lastname: Horvath
authors.forename: T
authors.initials: T
authors.lastname: Koszegi
authors.forename: S
authors.initials: S
authors.lastname: Ghosh
mesh_terms: D000328:Adult; D000368:Aged; D059248:Chemoradiotherapy; D015331:Cohort Studies; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D016629:Esophagectomy; D005260:Female; D006801:Humans; D018836:Inflammation Mediators / Q000097:blood; D008297:Male; D008875:Middle Aged; D009752:Nutritional Status; D057234:Preoperative Period; D011446:Prospective Studies; D016896:Treatment Outcome
chemical_list: D018836:Inflammation Mediators